Group One Trading’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-10,500
| Closed | -$294K | – | 8918 |
|
|
2022
Q1 | $294K | Buy |
+10,500
| New | +$288K | ﹤0.01% | 4392 |
|
|
2021
Q4 | – | Sell |
-5,400
| Closed | -$147K | – | 9130 |
|
|
2021
Q3 | $147K | Sell |
5,400
-4,700
| -47% | -$116K | ﹤0.01% | 5501 |
|
|
2021
Q2 | $173K | Buy |
10,100
+5,000
| +98% | +$93.6K | ﹤0.01% | 5385 |
|
|
2021
Q1 | $106K | Buy |
5,100
+300
| +6% | +$6.92K | ﹤0.01% | 5611 |
|
|
2020
Q4 | $110K | Buy |
4,800
+2,000
| +71% | +$38.1K | ﹤0.01% | 4500 |
|
|
2020
Q3 | $46K | Sell |
2,800
-43,400
| -94% | -$786K | ﹤0.01% | 4700 |
|
|
2020
Q2 | $626K | Buy |
46,200
+45,100
| +4,100% | +$525K | ﹤0.01% | 2447 |
|
|
2020
Q1 | $13K | Buy |
+1,100
| New | +$24.4K | ﹤0.01% | 4475 |
|
|
2019
Q4 | – | Sell |
-1,100
| Closed | -$19K | – | 5828 |
|
|
2019
Q3 | $19K | Hold |
1,100
| – | – | ﹤0.01% | 4370 |
|
|
2019
Q2 | $25K | Buy |
+1,100
| New | +$29.7K | ﹤0.01% | 4084 |
|
|
2019
Q1 | – | Sell |
-15,100
| Closed | -$426K | – | 5577 |
|
|
2018
Q4 | $426K | Buy |
15,100
+400
| +3% | +$11.7K | ﹤0.01% | 2091 |
|
|
2018
Q3 | $423K | Buy |
14,700
+12,300
| +513% | +$369K | ﹤0.01% | 2422 |
|
|
2018
Q2 | $90K | Sell |
2,400
-2,500
| -51% | -$98.1K | ﹤0.01% | 3635 |
|
|
2018
Q1 | $193K | Buy |
+4,900
| New | +$179K | ﹤0.01% | 2823 |
|
|
2017
Q1 | – | Sell |
-3,500
| Closed | -$42K | – | 5155 |
|
|
2016
Q4 | $42K | Hold |
3,500
| – | – | ﹤0.01% | 3357 |
|
|
2016
Q3 | $55K | Buy |
+3,500
| New | +$52.7K | ﹤0.01% | 3301 |
|
Group One Trading's XENT Position: Q2 2022 in Review
Group One Trading sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 14,086 shares — an estimated $395K sold.
Group One Trading first reported a position in XENT in Q3 2016 and held it in 13 quarters. The position peaked at $802K in Q3 2018. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Group One Trading reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Group One Trading sold 14,086 Intersect ENT, Inc shares in Q2 2022, an estimated $395K.
- Group One Trading first reported a position in Intersect ENT, Inc in Q3 2016 and held it in 13 quarters.
- Group One Trading's Intersect ENT, Inc position peaked at $802K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Group One Trading's 13F filing for Q2 2022, filed 11 Aug 2022.